Yvette van Norden

Suggest Changes
Learn More
BACKGROUND Lenalidomide (Len) has been proven effective both as monotherapy and in combination with rituximab for the treatment of chronic lymphocytic leukemia (CLL). Len has shown a distinct and(More)